期刊文献+

槲皮素磷脂复合物固体分散体和固体分散体的制备及评价(英文) 被引量:4

Quercetin-phospholipids complex solid dispersion and quercetin solid dispersion: preparation and evaluation
原文传递
导出
摘要 槲皮素在体外具有很多生物活性和药理作用,但是由于溶解度较差导致口服吸收生物利用度很低,极大地限制了在临床上的应用。本研究分别采用溶剂挥发法制备槲皮素固体分散体和槲皮素磷脂复合物固体分散体来改善槲皮素的体内吸收。XRD结果显示,槲皮素以无定型或分子状态高度分散于固体分散体和磷脂复合物固体分散体中,有助于提高其溶解度和溶出度。槲皮素固体分散体和磷脂复合物固体分散体分别将槲皮素的溶解度由(4.03±0.02)μg/mL提高至(26.91±0.06)μg/mL和(30.65±0.06)μg/mL,其中槲皮素在磷脂复合物固体分散体溶解度高于在固体分散体中的溶解度。体外溶出试验结果显示,固体分散体和磷脂复合物固体分散体的最大溶出度由9.57%分别提高至93.81%和94.16%。药动学研究结果显示,固体分散体和磷脂复合物固体分散体均可提高槲皮素的口服吸收生物利用度,生物利用度分别提高至149.49%和198.32%。重要的是槲皮素磷脂复合物固体分散体的生物利用度高于槲皮素固体分散体。因此,对于水溶性和透膜性均较差的药物来讲,磷脂复合物固体分散体更有效地促进药物吸收进而得到更高的生物利用度。 Quercetin(QUE)has many beneficial biological activities and pharmacological actions in vitro.However,its oral bioavailability in vivo was very poor due to poor solubility,and severely restricted its clinical applications.In this study,we prepared quercetin solid dispersion(QUE-SD)and quercetin phospholipids complex solid dispersion(QUE-PC-SD)by a solvent evaporation method to improve the absorption of QUE in vivo.The results of XRD of QUE-SD and QUE-PC-SD showed that QUE was dispersed homogeneously in an amorphous or molecular state in QUE-SD and QUE-PC-SD,which could contribute to improve the solubility and dissolution of QUE.The solubility of QUE-SD and QUE-PC-SD was enhanced from(4.03±0.02)μg/mL to(26.91=1=0.06)μg/mL and(30.65±0.06)μg/mL,respectively.The solubility of QUE-PC-SD was higher than that of QUE-SD.In vitro dissolution study,it was showed that the maximum dissolution of QUE(9.57%)from the QUE-SD and QUE-PC-SD was enhanced to 93.81%and 94.16%,respectively.The results of pharmacokinetic experiment indicated that the QUE-SD and QUE-PC-SD exhibited considerable enhancement in the oral bioavailability.The relative bioavailability of QUE-SD and QUE-PC-SD compared with QUE were 149.49%and 198.32%,respectively.In addition,the relative bioavailability of QUE-PC-SD was also higher than that of QUE-SD.Therefore,in regard to drugs with poor solubility and low permeation,an active constituent-PC-SD system could result to a better absorption and higher bioavailability.
作者 刘蒸生 郝海军 范明松 Zhengsheng Liu;Haijun Hao;Mingsong Fan(Changsha Kexin cancer hospital,Changsha 410000,China;Technique Center,Shanghai Leiyunshang Pharmaceutical Co.,Ltd.,Shanghai 201401,China)
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2019年第12期868-877,共10页 中国药学(英文版)
基金 National Science and Technology Major Projects “Major New Drugs Innovation and Development”(Grant No.2018ZX09201019-002-009)
关键词 槲皮素 固体分散体 磷脂复合物 生物利用度 Quercetin Solid dispersion Phospholipids complex Bioavailability
  • 相关文献

参考文献8

二级参考文献61

  • 1袁恒杰,陈大为,范立君.尼群地平多晶型化学稳定性影响因素考察[J].中国医院药学杂志,2004,24(11):691-693. 被引量:6
  • 2荆新保,周小顺,杨祥良.羟喜树碱固体分散体的制备及体外溶出[J].中国医院药学杂志,2005,25(4):385-386. 被引量:5
  • 3郭建平,孙其荣.葛根化学成分及临床应用研究概况[J].药学实践杂志,1996,14(3):146-148. 被引量:36
  • 4王艳梅,吕立勋.黄豆苷元的药理作用及临床应用[J].中国药师,2007,10(9):910-912. 被引量:27
  • 5Wei W, Shi S J, Liu J, et al. Lipid nanoparticles loaded with lO-hydroxycamptothecin phospholipid complex developed for the treatment of hepatoma in clinical application [ J ]. J Drug Target, 2010, 18(7) : 557.
  • 6Hao H J, Jia Y Z, Han R. Phytosomes: an effective approach to enhance the oral bioavailability of active constitutents extracted from plants [J]. Chin Pharm Sci, 2013, 22(5) :385.
  • 7Wu X C, Hao H J, Liu Y X, et aL Bioavai|ability of 10-hydroxy- camptothecinphospholipid complex loaded by solid dispersion and lipid based formulations [ J ]. J Chin Pharm Sci, 2015, 24(12) :780.
  • 8国家药品监督管理局.WS1-XG-003-2001.国家药品西药标准(化学药品地标升国标第十六册)[S].北京:2002.
  • 9KORSMEYER R W, GURNY R,D0ELKER E, et al. Mechanismsof solute release from porous hydrophilic polymers[J].Int J Pharni,1983,15(1):25-35.
  • 10CRAIG D Q. The mechanism of drug release from soliddispersions in water-soluble polymers [J]. Int J Pharm,2002,231(2):131-144.

共引文献66

同被引文献45

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部